The DOI matches its Crossref record; 188 of the 195 references it cites were found in a registry or an index.
p53, cancer and the immune response
Open accessAbstract
The importance of cancer-cell-autonomous functions of the tumour suppressor p53 (encoded by TP53) has been established in many studies, but it is now clear that the p53 status of the cancer cell also has a profound impact on the immune response. Loss or mutation of p53 in cancers can affect the recruitment and activity of myeloid and T cells, allowing immune evasion and promoting cancer progression. p53 can also function in immune cells, resulting in various outcomes that can impede or support tumour development. Understanding the role of p53 in tumour and immune cells will help in the development of therapeutic approaches that can harness the differential p53 status of cancers compared with most normal tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These mutations can affect the tumor immune microenvironment (TIME) by altering cytokine expression and regulating the tumor’s sensitivity to immune checkpoint inhibitors.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [610]
In the citing paper
“It is widely accepted that gene mutations, including those affecting undruggable proteins, have a significant impact on the efficacy of cancer immunotherapy.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [610]
In the citing paper
“For examples, cancer cells with functional wild-type genes tend to have a desirable cancer-restrictive TIME, while an imbalance in their expression can create a cancer-supportive TIME.610,611”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [610]
In the citing paper
“In brief, the status of genes can influence tumor cells not only through the impact of wild-type gene loss but also through their effects on the TIME.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [610]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,492
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationIFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K. R., Signer, S. H., Davidson, N. E., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,730
Flagged first, then by citations
7 of the 195 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 337
Zhang, Z., Li, J., Zeng, P., Gao, W., & Tian, X. (2021) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-3449-8 · Cited by 5
Chakraborty, S., Carnazza, M. A., Jarboe, T., DeSouza, N. R., Li, X.-M., Moscatello, A. L., Geliebter, J., & Tiwari, R. K. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-83282-7_2 · Cited by 5
Şahin, İ., George, A., Zhang, S., Huntington, K. E., Ordulu, Z., Zhou, L., & El‐Deiry, W. S. (2021) · Oncotarget · doi:10.18632/oncotarget.28086 · Cited by 5
Integrated multi-optosis model for pan-cancer candidate biomarker and therapy target discovery
de Souza, E. R., Nogueira, H. A. C., Francisco, R. D. S., Garcia, A. B., & Medina‐Acosta, E. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1630518 · Cited by 5
p53: An Immune Ecosystem Manipulator
Nian, Z., Dou, Y., & Wei, H. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3628 · Cited by 4
Canine Transmissible Venereal Tumour: A Natural Model of Immune Evasion in Comparative Oncology
Duzanski, A. D. P., López-Valbuena, F. D., Osorio-Zambrano, W. F., González-Zambrano, C. M., Flórez, L. M. M., & Rocha, N. S. (2026) · Veterinary and Comparative Oncology · doi:10.1111/vco.70045 · Cited by 4
Chen, H., Liu, S., Wu, S., Nong, X., Liu, N., & Li, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112196 · Cited by 4
Crafting Iron Oxides for Next-Generation Biomedical Applications
Amrillah, T., Notodidjojo, B. A., Kalimanjaro, M., Prastika, R. A., Nurrahman, A. M., Taufiq, A., Santoso, D., & Setyawan, D. (2024) · Crystal Growth & Design · doi:10.1021/acs.cgd.4c00015 · Cited by 6
Ashique, S., Debnath, B., Ramzan, M., Taj, T., Islam, A., Chaudhary, P., Kaushik, M., Garg, A., Sen, A., Raveendran, C., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118308 · Cited by 5
TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
Zingarelli, F., Zannoni, L., & Curti, A. (2022) · Hemato · doi:10.3390/hemato3040050 · Cited by 6
Wang, H.-L., Ye, Z.-M., He, Z.-Y., Huang, L. H., & Liu, Z. (2023) · Hereditas · doi:10.1186/s41065-023-00267-y · Cited by 4
Evaluating targeted therapies in older patients with TP53 -mutated AML
Sabile, J. M. G., Swords, R. T., & Tyner, J. W. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2344057 · Cited by 4
Fang, J., Zou, M., Yang, M., Cui, Y., Pu, R., & Yang, Y.-F. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01053-8 · Cited by 4
Discovery of novel covalent stabilizers for p53 Y220C using structure-based drug discovery methods
Wen, Y., Xu, P., Chen, Y., Meng, J., Zheng, M., Zhang, S., Teng, D., & Li, X. (2025) · Molecular Diversity · doi:10.1007/s11030-024-11095-1 · Cited by 4
Mezi, S., Pomati, G., Zizzari, I. G., Filippo, A. D., Cerbelli, B., Cirillo, A., Fiscon, G., Amirhassankhani, S., Valentini, V., VINCENTIIS, M. D., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112732 · Cited by 4
Oscillation and bistable switching dynamical behavior of p53 regulated by PTEN upon DNA damage
Liu, N., Yang, H., Li, S., Wang, D., & Yang, L. (2021) · Acta Mechanica Sinica · doi:10.1007/s10409-020-01041-3 · Cited by 4
Carneiro, A. P. C. D., Monteiro, F. S. M., & Soares, A. (2021) · Kidney Cancer · doi:10.3233/kca-210111 · Cited by 4
Curing the Incurable: TP53 Mutated Myeloid Neoplasms
Punwani, N., & Chhabra, S. (2025) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2025.07.013 · Cited by 3
Naik, K. A. P., Kethavath, S. N., Rosangzula, K., Saikrishna, J., Sangeetha, R., Patlolla, R. R., Chandgude, A. H., & Banoth, L. (2026) · Springer eBooks · doi:10.1007/978-981-95-5071-5_12 · Cited by 3
Chen, D., Cao, H., Zheng, X., Wang, H., Han, Z., & Wang, W. (2024) · BMC Cancer · doi:10.1186/s12885-024-12790-w · Cited by 3
Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer
Liu, D., Liu, L., Che, X., & Wu, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1525345 · Cited by 4
Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells
Abdo, E., Ismail, M. A., Hadidi, S. A., Al-Mrahleh, M., Saleh, T., Zihlif, M., & Ababneh, N. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0311615 · Cited by 3
Ji, Y., Jiang, J., Hu, L., Peng, L., Zhou, M., Hu, S., Wang, M., Ji, Y., Liu, X., Yan, D., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01155-y · Cited by 3
A Narrative Review of the TP53 and Its Product the p53 Protein
Foroutan, B. (2023) · OBM Genetics · doi:10.21926/obm.genet.2302185 · Cited by 8
Dai, C., Man, Y., Zhang, L., Zhang, X., Xie, C., Wang, S., Zhang, Y., Guo, Q., Zou, L., Hong, H., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01964-3 · Cited by 3
PI 5 P 4 K inhibitors: promising opportunities and challenges
Takeuchi, K., Nagase, L., Kageyama, S., Kanoh, H., Oshima, M., Iio, A., Ikeda, Y., Fujii, Y., Kondo, S., Osaka, N., et al. (2025) · FEBS Journal · doi:10.1111/febs.17393 · Cited by 3
Ansari, A., Szczesnowska, A., Haddad, N. F., Elbediwy, A., & Wehida, N. (2025) · Non-Coding RNA · doi:10.3390/ncrna11040061 · Cited by 4
The p53 Pathway Related Genes Predict the Prognosis of Colon Cancer
Feng, J. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s346280 · Cited by 3
Targeting P53 Gene in Breast Cancer
Abuhagr, A. M., Musa, E. B., Attir, O. A., & Alati, R. M. O. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44is7.2746 · Cited by 2
Hamada, A., Kita, Y., Sakatani, T., Nakamura, K. D., Takada, H., Ikeuchi, R., Koike, S., Masuda, N., Murakami, K., Sano, T., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03311-5 · Cited by 2
Can TP53, TMB and TME Expand the Immunotherapy Benefit in Metastatic Colorectal Cancer?
Specchia, M., Drittone, D., Mazzotti, E., & Mazzuca, F. (2025) · Cancers · doi:10.3390/cancers17243984 · Cited by 2
Yun¹, H. J., Park², C. H., Yun, D., Shin, H.-R., Lee¹, J. D., Park⁴, C., Kim², K., Shim, H., Sim, H., Kim, S. M., et al. (2026) · 癌症：英文版 · doi:10.34133/cancomm.0013 · Cited by 2
Can Glycosylation Mask the Detection of MHC Expressing p53 Peptides by T Cell Receptors?
Nguyen, T., Lane, D. P., & Verma, C. S. (2021) · Biomolecules · doi:10.3390/biom11071056 · Cited by 2
Wang, B., Katsube, T., Tanaka, K., Ninomiya, Y., Hirakawa, H., Liu, C., Maruyama, K., Varès, G., Kito, S., Nakajima, T., et al. (2022) · Life · doi:10.3390/life12040565 · Cited by 2
Lindemann, A., Brandes, F., Borrmann, M., Meidert, A. S., Kirchner, B., Steinlein, O. K., Schelling, G., Pfaffl, M. W., & Reithmair, M. (2022) · Oncology Reports · doi:10.3892/or.2022.8465 · Cited by 2
Epitope identification for p53R273C mutant
Zhang, J., Liu, M., Chen, Y., Zhou, Z., Wang, P., Yu, Y., & Jiao, S. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.752 · Cited by 1
Harnessing the ROS for Cancer Treatment
Osama, A., Zhang, J., & Fang, J. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_255-1 · Cited by 2
Wild-Type TP53 Predicts Poor Prognosis in Lower-Grade Glioma via TP53-CXCL14-GATA3 Axis
El‐Arabey, A. A., Alkhalil, S. S., Alafaleq, N. O., Al-Shouli, S., Mohamed, S. S. E. M., Al‐Shouli, S. T., & Abdalla, M. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02323-w · Cited by 2
Cao, X., Zhang, Y., Liu, D., Zhang, J. P., Wei, Z. J., Xiong, M., Sun, R., Lu, Y., Zhou, J., Zhao, Y., et al. (2020) · Europe PMC (PubMed Central) · doi:10.3760/cma.j.issn.0253-2727.2020.11.005 · Cited by 2
Yasin, A., Yasin, A. R., Azam, M. R., Raza, A., Nazir, R., & Abdalla, R. A. E. (2022) · Applied Sciences · doi:10.3390/app12115748 · Cited by 2
Li, H. J., Ge, Y., Fei, G., Wang, Z., Wang, S., & Wei, P. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-992 · Cited by 2
Tang, L., Li, Y., Shen, L., Li, N., Shen, L., & Li, Z. (2023) · PubMed Central · Cited by 2
Acute Myeloid Leukemia Genomics: Impact on Care and Remaining Challenges
Eisfeld, A., & Mardis, E. R. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvad171 · Cited by 2
Shi, A., Lin, C., & Lyu, J. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70009 · Cited by 1
The guardian of the genome meets a viral master gene regulator at a biomolecular condensatePreprint
Borkosky, S. S., Fassolari, M., Campos-León, K., Rossi, A. H., Salgueiro, M., Pascuale, C. A., Martínez, R. P., Gaston, K., & Gay, G. D. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.09.479752 · Cited by 2
Molecular Diagnostics of Cancer [Working Title]
Piccaluga, P. P. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111118 · Cited by 1
Sahyon, H. A. E., Alharbi, N. S., Asad, Z., Shishtawy, M. E., & Derbala, S. A. (2024) · Children · doi:10.3390/children11091035 · Cited by 1
Sun, D. S., Yoon, J., Kim, Y., & Won, H. S. (2024) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20468 · Cited by 1
Wang, Y. (2024) · American Journal of Translational Research · doi:10.62347/vkmz3204 · Cited by 1
Mechanisms of drug resistance to neoadjuvant chemotherapy in breast cancer
Aliev, K. A., Zyablitskaya, E. Y., Makalish, T. P., Sorokina, L. E., & Asanova, E. (2024) · Advances in molecular oncology · doi:10.17650/2313-805x-2024-11-3-103-113 · Cited by 1
Mathematical and Computational Modelling of Immune Cell Responses in Cell Migration
Benson, T. O. (2024) · Learning materials in biosciences · doi:10.1007/978-3-031-64532-7_15 · Cited by 1
Growth suppressing effect of Fagonia arabica extracts on cancerous cell line
Fatima, R., Batool, A., Ijaz, T., Khan, S. U., Akhtar, Y., Erċışlı, S., Almutairi, S. M., Elshikh, M. S., Saleem, A., & Javed, M. A. (2025) · Cytotechnology · doi:10.1007/s10616-024-00663-w · Cited by 1
Czekay, R., & Higgins, P. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-55254-0_7-1 · Cited by 1
Photobiomodulation by infrared radiation on hallmarks of cancer
Ferreira, A. C. D. S., Farias, T. G., Borges, A. J. C., da Silva, M. A., Pires, B. R. B., Mencalha, A. L., & da Fonseca, A. D. S. (2025) · Lasers in Medical Science · doi:10.1007/s10103-025-04625-2 · Cited by 1
Mansouri, R., Heydarpour, F., Yari, K., Naseroleslami, M., & Payandeh, M. (2025) · BMC Cancer · doi:10.1186/s12885-025-15070-3 · Cited by 1
Unveiling oncogene-induced senescence: a new frontier in prostate cancer prognosis and therapy
Peng, Y., Qiu, X., Cai, J., Li, Y., & Wei, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-03893-2 · Cited by 2
Gou, X., Chen, H., Diolaiti, M. E., & Ashworth, A. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0173 · Cited by 1
Zhang, M.-Y., Sun, R.-Q., Min, Q., Zhu, Y.-Q., Qin, S.-K., & Guo, Q.-L. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i6.113529 · Cited by 1
Schwer, M., Aldea, S., Engelhardt, M., Stahlecker, J., Rheinganz, J., Langkamp, A., & Boeckler, F. M. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s598622 · Cited by 1
Niu, S., Liu, C., & Deng, Q. (2026) · Cell Transplantation · doi:10.1177/09636897261449351 · Cited by 1
Stukan, А. I., Goryainova, А. Y., Chukhray, O. Y., Maksimenko, S. D., Имянитов, Е. Н., Викторович, Ш. С., & Khachmamuk, Z. K. (2022) · Tumors of female reproductive system · doi:10.17650/1994-4098-2022-18-2-29-39 · Cited by 1
Ntwasa, M. M. (2024) · Cells · doi:10.3390/cells13131124 · Cited by 2
Bobak, A., Steves, M., McMahon, E., Spahiu, M., Rahman, A. S. W., Casarcia, N., Banerjee, S., & Bishayee, A. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156850 · Cited by 1
Proteomic Changes in Cancer Cell Lines as a Result of Bacterial Infection
Ren, B., Weke, K., Hardie, D. B., Goncheva, M. I., Hupp, T. R., Alfaro, J. A., Pětrošová, H., & Goodlett, D. R. (2025) · PROTEOMICS · doi:10.1002/pmic.70062 · Cited by 1
Bunz, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-99387-0_7 · Cited by 1
Xu, J., Wu, X., Chen, J., Cheng, Y., & Zhang, X. (2023) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2023.100552 · Cited by 1
Trovato, M. C., & Valenti, A. (2024) · Preprints.org · doi:10.20944/preprints202407.1319.v1
Kudo‐Saito, C. (2020) · Journal of Japanese Society of Oral Oncology · doi:10.5843/jsot.32.144
Zhang, Z., Zeng, P., Gao, W., Tian, S., Zhou, Q., Wang, Y., Zhu, W., & Tian, X. (2020) · doi:10.21203/rs.3.rs-101900/v1
Alison, M. R. (2020) · Wiley eBooks · doi:10.1002/9780470015902.a0029230
Triantafyllidis, C. P., Barberis, A., Miar, A., Gjerga, E., Charlton, P. V., Hartley, F., van Bijsterveldt, L., Sáez-Rodríguez, J., & Buffa, F. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.23.497293
Xiao, J., Yuan, W., Zhu, X., Yan, Y., Li, W., Wu, F., Mao, B., Zhang, J., Du, Y., Zhu, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2078140/v1
Mutation profile of diffuse large B-cell lymphoma with relapses in the central nervous system
Voropaeva, E. N., Pospelova, T. I., Karpova, V., Churkina, M. I., Vyatkin, Y. V., Ageeva, T. A., & Maksimov, V. N. (2022) · Advances in molecular oncology · doi:10.17650/2313-805x-2022-9-3-69-84
Immune Allies to Cancer Metastasis
Kudo‐Saito, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_56-1
More than the Genes: The Tumor Microenvironment in Adrenal Gland Carcinoma
Petrelli, F., Rocca, B. J., Arganini, M., & Ambrosio, M. R. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_81
The Effect of Cytotoxic CD8+ T-Cells Secretory Proteins on Hypoxic Pancreatic Cancer CellsPreprint
Abdo, E., Ismail, M. A., Hadidi, S. A., Al-Mrahleh, M., Zihlif, M., & Ababneh, N. A. (2023) · Research Square · doi:10.21203/rs.3.rs-2505088/v1
Research Progress of TP53 Gene Abnormality in Osteosarcoma
陈, 杨. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133529
Awasthi, S., Berglund, A., Abraham-Miranda, J., Rounbehler, R. J., Kensler, K. H., Serna, A. N., Vidal, A. C., You, S., Freeman, M. R., Davicioni, E., et al. (2023) · doi:10.1158/1078-0432.c.6530069
Awasthi, S., Berglund, A., Abraham-Miranda, J., Rounbehler, R. J., Kensler, K. H., Serna, A. N., Vidal, A. C., You, S., Freeman, M. R., Davicioni, E., et al. (2023) · doi:10.1158/1078-0432.c.6530069.v1
Targeting Immune Determinants of Creating Tumor Heterogeneity in Lung Cancer
Kudo‐Saito, C., & Kinoshita, T. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2023_169
Luo, X., Zhang, Z., Wang, Y., Sun, M., Hu, D. X., Jiang, J., Wang, Y., Ji, X., Chen, X., Zhang, B., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3205248/v1
Ferroptosis-related genes are involved in the activity of resveratrol against esophageal cancerPreprint
Chen, X., Chen, H., Hu, P., Lin, Y., Zou, Z., & Chen, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3275654/v1
Xue, B., Luo, X., Liu, Y., Ye, S., Zhou, L., Lu, Y., Fu, J., Qian, W., Wang, L., Li, P., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3683636/v1
Restoration of Tumor Suppression to Cancer Carrying p53 Mutations
Amin, M. N., & Liu, Y. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003642
WANG, L., Yin, Y., Liu, P., Chen, H., & XU, M. (2023) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20428
Sun, Z., Chen, H., & Liu, Y. (2023) · Science of Advanced Materials · doi:10.1166/sam.2023.4544
Deng, X., Cui, W., Li, F., Chen, X., & Wang, S. (2024) · Journal of Biobased Materials and Bioenergy · doi:10.1166/jbmb.2024.2369
Comprehensive analysis of the potential pathogenesis of COVID-19 infection and liver cancer
Rong, Y., Tang, M., Liu, S., Li, X., & Cai, H. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i2.436
The Molecular Landscape of Lung Metastasis in Primary Head and Neck Squamous Cell Carcinomas
Thirumani, L., Helan, M., Vijayaraghavan, S., Mohamed, U. J., Vimal, S., & Madar, I. H. (2024) · Cureus · doi:10.7759/cureus.57497
Wei, Y., Cheng, X., Deng, L., Dong, H., Wei, H., Xie, C., Tuo, Y., Li, G., Yu, D., & Cao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22620572
Wang, H.-L., Ye, Z.-M., He, Z.-Y., Huang, L., & Liu, Z. (2023) · Figshare · doi:10.6084/m9.figshare.22602275
Lyu, X., Li, G., & Qiao, Q. (2021) · Figshare · doi:10.6084/m9.figshare.14570146
Wang, H.-L., Ye, Z.-M., He, Z.-Y., Huang, L., & Liu, Z. (2023) · Figshare · doi:10.6084/m9.figshare.22602278
Cheng, Q., Wang, W., Lv, Z., Ji, W., Liu, J., Zhou, X., & Yang, Y. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2182
Association of P53 Gene and Colorectal Cancer in Iran
Seyedinnavadeh, S.-A., Neisanghalb, M. H., Pazhooha, M., & Saleh, N. (2024) · General Surgery and Clinical Medicine · doi:10.33140/gscm.02.03.05
Lingling, L., Xu, R., Wei, M., Zhong, K., Han, W. L., Han, X., Fan, Z. M., Yang, S. X., Wang, R., Ma, L., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5144640
Mangasarova, Y. K., Вениаминовна, Б. Б., Обухова, Т. Н., Равильевна, А. Р., Abramova, T. V., Магомедова, А. У., Chabaeva, Y. A., Gabeeva, N. G., Zvonkov, E. E., & Sudarikov, A. B. (2025) · Гематология и трансфузиология · doi:10.35754/0234-5730-2025-70-1-27-39
CAML Model for Computational Biology
Chaudhuri, P. P., Dutta, A., Choudhury, S. P., Chowdhury, D. R., & Hazari, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-1501-8_5
张, 健. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551679
Metadata
- Authors
- Blagih, J., Buck, M. D., & Vousden, K. H.
- Affiliations
- The Francis Crick Institute (GB)
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2020-03-01
- Volume
- 133
- Issue
- 5
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W3009145316
- Cited by
- 333
- References
- 195
- Citations by year
- 2026: 27 · 2025: 48 · 2024: 63 · 2023: 63 · 2022: 63 · 2021: 51 · 2020: 18
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Cell Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- HighWire Press Open Archive (submittedVersion)
- The Francis Crick Institute (cc-by)
- Funders
- Cancer Research UK (C596/A26855, FC001557)
- Francis Crick Institute
- Medical Research Council (FC001557)
- Wellcome Trust (FC001557)
- Canadian Institutes of Health Research
- European Molecular Biology Organization (ALTF 1096-2018)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- p53, antitumor immunity, immune evasion, TP53 mutation, myeloid cells, T cells, tumor progression, cancer immunotherapy, cancer cells
- MeSH terms
- Humans, Immunity, Mutation, Neoplasms, Tumor Suppressor Protein p53
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
